Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary cutaneous B-cell lymphomas.

H M Prince1, L M Yap, R Blum

  • 1Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia. mprince@petermac.unimelb.edu.au

Clinical and Experimental Dermatology
|February 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Assessment of image quality on the diagnostic performance of clinicians and deep learning models: Cross-sectional comparative reader study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

The British journal of dermatology·2020
Same author

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

The British journal of dermatology·2020
Same author

A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome.

The British journal of dermatology·2019
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

B-cell lymphomas are a significant part of skin non-Hodgkin lymphoma (NHL). Controversy exists between the European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classification systems, impacting patient management.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Cutaneous B-cell lymphomas (CBCLs) represent a substantial proportion, up to 25%, of primary cutaneous non-Hodgkin lymphoma (NHL).
  • Current clinical practice and research interpretation are influenced by differing classification systems for these conditions.

Purpose of the Study:

  • To address the controversy surrounding the classification systems for cutaneous B-cell lymphomas.
  • To clarify the impact of different classifications on data interpretation and patient management strategies.

Main Methods:

  • Review of existing literature on cutaneous B-cell lymphoma classification.
  • Comparative analysis of the European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classification systems.

Related Experiment Videos

Main Results:

  • Significant discrepancies exist between the EORTC and WHO classification systems for CBCLs.
  • These classification differences lead to varied interpretations of epidemiological data and treatment outcomes.

Conclusions:

  • The choice of classification system for cutaneous B-cell lymphomas has profound implications for research and clinical decision-making.
  • Standardization or clear guidelines are needed to reconcile the EORTC and WHO systems for improved patient care.